Implantable Neurostimulation Devices Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Implantable Neurostimulation Devices Market Size Likely To Evolve From 2025 Through 2034?

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $5.02 billion in 2024 to $5.62 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing demand for non-pharmacological treatments, growing demand for minimally invasive procedures, growing geriatric population, increasing the wide range of psychiatric disorders, and increasing incidence of chronic diseases.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $8.86 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to rising prevalence of neurological disorders, rise in prevalence of lifestyle diseases, rising awareness, increase in spinal cord injuries, and increasing healthcare expenditure. Major trends in the forecast period include sensing technology, increasing advances in neurostimulation technologies, technologically advanced products, incorporating closed-loop systems, and integrating wireless technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp

Which Industry Drivers Are Expected To Accelerate The Implantable Neurostimulation Devices Market From 2025 To 2029?

The rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulation device market going forward. A neurological disorder is any condition that affects the structure or function of the nervous system, resulting in various symptoms such as paralysis, seizures, and cognitive impairments. The increased exposure to risk factors such as high blood pressure, developmental abnormalities, trauma or injury leads to higher detection rates of neurological disorders. Implantable neurostimulation devices are used for neurological disorders to modulate nerve activity and alleviate symptoms when other treatments are ineffective or insufficient. For instance, in 2024, according to the Alzheimer’s Association, a US-based non-profit voluntary health organization, an estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s disease, with 73% being age 75 or older. This number is projected to grow to 12.7 million by 2050. Therefore, the rising prevalence of neurological disorders will drive the implantable neurostimulation device market.

What Are The Major Segments Identified In The Implantable Neurostimulation Devices Market?

The implantable neurostimulation devicesmarket covered in this report is segmented –

1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types

2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices

2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators

3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders

4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence

5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression

6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies

What Long-Term Trends Will Shape The Future Growth Of The Implantable Neurostimulation Devices Industry?

Major companies operating in the implantable neurostimulation devices market are focused on developing technologically advanced products, such as spinal cord stimulation (SCS) systems, to relieve chronic pain conditions. A spinal cord stimulation (SCS) system is a medical device that uses electrical impulses to modulate nerve activity in the spinal cord to alleviate chronic pain and improve the quality of life for patients when other treatments are ineffective. For instance, in December 2022, Abbott, a US-based medical device company, announced the U.S. Food and Drug Administration (FDA) approval for the Eterna spinal cord stimulation (SCS) system. The Eterna SCS is the market’s smallest implantable, rechargeable spinal cord stimulator, engineered for maximum daily comfort. It features Abbott’s proprietary BurstDR stimulation technology, which mimics natural brain firing patterns for superior pain relief and is preferred by 87% of patients over traditional tingling stimulation. With the lowest recharging needs, requiring as few as five recharges annually due to Xtend energy technology, Eterna ensures convenience. It supports full-body MRI scans with TotalScan technology and is adaptable to future advancements without replacement. Abbott’s mobile app integration also enables real-time tracking of battery life and charging status on iPhone devices.

Which Major Industry Participants Are Leading The Implantable Neurostimulation Devices Market Growth?

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/implantable-neurostimulation-devices-global-market-report

How Do Regional Market Performances Compare Within The Implantable Neurostimulation Devices Industry?

North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Implantable Neurostimulation Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=19520&type=smp

Browse Through More Reports Similar to the Global Implantable Neurostimulation Devices Market 2025, By The Business Research Company

Neurostimulation Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Implantable Biomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-biomaterials-global-market-report

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795